소아중환자에서 분무용 살부타몰 용량과 심박수와의 상관관계 분석
Correlation Analysis between Nebulized-Salbutamol Dose and Heart Rate in Critically Ill Pediatric Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Nebulized-salbutamol is often used for patients hospitalized in the pediatric intensive care unit (PICU) in need of respiratory support. However, there is a lack of references to establish a guideline for dosage adjustment according to each age group. Thus, the purpose of this study was to analyze the correlation between the dose of nebulized-salbutamol and heart rate (HR) in critically ill pediatric patients. Methods : This study included critically ill pediatric patients younger than age 18, who stayed in the PICU at Seoul National University Children’s Hospital July 1, 2015 July 31, 2018. The correlation between the change of HR and the dose of nebulized-salbutamol was analyzed. After that, there was an effort to identify further risk factors which can contribute to increasing HR during PICU hospitalization. Results : There was a total of 340 cases of 87 patients who were administered nebulized-salbutamol within the first 24 hours of PICU hospitalization. There was no statistical difference in HR changes between the high dosage group (≥0.2 mg/kg/dose) and the low dosage group ( 0.2 mg/kg/dose) for the first 24 hours of administration (p=0.058). The subgroup analysis was conducted using 268 cases excluding 72 cases where body temperature change was observed. There was significant increase of HR in the high dosage group (p=0.017). Twenty-five of 87 patients showed a more rapid HR after the administration of nebulized-salbutamol during PICU hospitalization. Among patients younger than age 36 months, there was a statistically significant correlation between HR rise (OR=8.739; 95% CI, 2.146-35.590; p=0.002) and the high dosage of nebulized-salbutamol (OR=4.204; 95% CI, 1.384-12.776; p=0.011). Conclusions : The use of high dosage nebulized-salbutamol in critically ill pediatric patients may have the potential to increase HR. Thus, close monitoring is recommended when it is administered to young patients with high dosage.
Abstract
Background : Nebulized-salbutamol is often used for patients hospitalized in the pediatric intensive care unit (PICU) in need of respiratory support. However, there is a lack of references to establish a guideline for dosage adjustment according to each age group. Thus, the purpose of this study was to analyze the correlation between the dose of nebulized-salbutamol and heart rate (HR) in critically ill pediatric patients. Methods : This study included critically ill pediatric patients younger than age 18, who stayed in the PICU at Seoul National University Children’s Hospital July 1, 2015 July 31, 2018. The correlation between the change of HR and the dose of nebulized-salbutamol was analyzed. After that, there was an effort to identify further risk factors which can contribute to increasing HR during PICU hospitalization. Results : There was a total of 340 cases of 87 patients who were administered nebulized-salbutamol within the first 24 hours of PICU hospitalization. There was no statistical difference in HR changes between the high dosage group (≥0.2 mg/kg/dose) and the low dosage group ( 0.2 mg/kg/dose) for the first 24 hours of administration (p=0.058). The subgroup analysis was conducted using 268 cases excluding 72 cases where body temperature change was observed. There was significant increase of HR in the high dosage group (p=0.017). Twenty-five of 87 patients showed a more rapid HR after the administration of nebulized-salbutamol during PICU hospitalization. Among patients younger than age 36 months, there was a statistically significant correlation between HR rise (OR=8.739; 95% CI, 2.146-35.590; p=0.002) and the high dosage of nebulized-salbutamol (OR=4.204; 95% CI, 1.384-12.776; p=0.011). Conclusions : The use of high dosage nebulized-salbutamol in critically ill pediatric patients may have the potential to increase HR. Thus, close monitoring is recommended when it is administered to young patients with high dosage.
참고문헌 (16)
- O'Callaghan C, "Nebulized salbutamol does have a protective effect on airways in children under one year old", Arch Dis Child, 63(5), pp.479~483 (1988)
- Schuh S, "High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma", Pediatrics, 83(4), pp.513~518 (1989)
- Schuh S, "Nebulized albuterol in acute childhood asthma : Comparison of two doses", Pediatrics, 86(4), pp.509~513 (1990)
- Edgell H, "Shortterm cardiovascular and autonomic effects of inhaled salbutamol", Respir Physiol Neurobiol, 231, pp.14~20 (2016)
- Singh BS, "Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates", J Pediatr, 141(1), pp.16~20 (2002)
- Malcolm R., "Adverse effects of β-agonists", J Allergy Clin Immunol, 110(6Suppl), pp.322~328 (2002)
- Reinelt P, "Incidence and type of cardiac arrhythmias in critically ill patients : a single center experience in an medical-cardiological ICU", Intensive Care Med, 27(9), pp.1466~1473 (2001)
- Annane D, "Incidence and prognosis of sustained arrhythmias in critically ill patients", Am J Respir Crit Care Med, 178(1), pp.20~25 (2008)
- "PrVentolin respirator solution" (2017)[URL]
- National Asthma Education and Prevention Program, "Expert panel report: Guidelines for the diagnosis and management of asthma update on selected topics-2002", J Allergy Clin Immunol, 110(5 Suppl), pp.S141~S219 (2002)
- Francis P. V. Maesen, "The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations", Chest, 99(6), pp.1367~1373 (1991)
- Andrade Capuchinho-Junior, "One hour effects of salbutamol and formoterol on blood pressure, heart rate and oxygen saturation in asthmatics", Rev Port Pneumol, 14(3), pp.353~361 (2008)
- Khorfan FM, "Effects of nebulized nronchodilator therapy on heart rate and arrhythmias in critically ill adult patients", Chest, 140(6), pp.1466~1472 (2011)
- Cekici L, "Short term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects : a placebo-controlled study", Br J Clin Pharmacol, 67(4), pp.394~402 (2009)
- Davies P, "The relationship between body temperature, heart rate and respiratory rate in children", Emerg Med J, 26(9), pp.641~643 (2009)
- Birgul Say, "Supraventricular tachycardia after nebulized salbutamol therapy in a neonate: Case report", Arch Argent Pediatr, 113(2), pp.e98~e100 (2015)